These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6332053)
1. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage. Stockley RA; Morrison HM; Smith S; Tetley T Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053 [TBL] [Abstract][Full Text] [Related]
2. Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples. Morrison HM; Kramps JA; Dijkman JH; Stockley RA Thorax; 1986 Jun; 41(6):435-41. PubMed ID: 3491440 [TBL] [Abstract][Full Text] [Related]
3. Acid-stable low molecular mass proteinase inhibitors in human lung lavage. Smith SF; Guz A; Burton GH; Cooke NT; Tetley TD Biol Chem Hoppe Seyler; 1986 Mar; 367(3):183-9. PubMed ID: 3085687 [TBL] [Abstract][Full Text] [Related]
4. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase. Morrison HM; Kramps JA; Afford SC; Burnett D; Dijkman JH; Stockley RA Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636 [TBL] [Abstract][Full Text] [Related]
5. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Morrison HM; Kramps JA; Burnett D; Stockley RA Clin Sci (Lond); 1987 Mar; 72(3):373-81. PubMed ID: 2434283 [TBL] [Abstract][Full Text] [Related]
6. The elastase inhibitory capacity and the alpha 1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects. Boudier C; Pelletier A; Gast A; Tournier JM; Pauli G; Bieth JG Biol Chem Hoppe Seyler; 1987 Aug; 368(8):981-90. PubMed ID: 3311075 [TBL] [Abstract][Full Text] [Related]
7. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Smith SF; Guz A; Cooke NT; Burton GH; Tetley TD Clin Sci (Lond); 1985 Jul; 69(1):17-27. PubMed ID: 3905206 [TBL] [Abstract][Full Text] [Related]
8. The mucosal defence capacity against proteolytic leukocyte enzymes. Tegner H; Fryksmark U; Ohlsson K Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236 [TBL] [Abstract][Full Text] [Related]
9. The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects. Jochum M; Pelletier A; Boudier C; Pauli G; Bieth JG Am Rev Respir Dis; 1985 Oct; 132(4):913-4. PubMed ID: 3876796 [TBL] [Abstract][Full Text] [Related]
10. Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. Afford SC; Stockley RA; Kramps JA; Dijkman JH; Burnett D Anal Biochem; 1985 Nov; 151(1):125-30. PubMed ID: 3853960 [TBL] [Abstract][Full Text] [Related]
11. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494 [TBL] [Abstract][Full Text] [Related]
12. Studies on the pathogenesis of the adult respiratory distress syndrome. McGuire WW; Spragg RG; Cohen AB; Cochrane CG J Clin Invest; 1982 Mar; 69(3):543-53. PubMed ID: 7037851 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs. Morrison HM; Afford SC; Stockley RA Thorax; 1984 Jul; 39(7):510-6. PubMed ID: 6611602 [TBL] [Abstract][Full Text] [Related]
14. The assessment of alpha 1 proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Afford SC; Burnett D; Campbell EJ; Cury JD; Stockley RA Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1065-74. PubMed ID: 3265875 [TBL] [Abstract][Full Text] [Related]
15. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor. Ying QL; Simon SR Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916 [TBL] [Abstract][Full Text] [Related]
16. Determination of elastase inhibitory activity of alpha 1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates. Kramps JA; Morrison HM; Burnett D; Dijkman JH; Stockley RA Scand J Clin Lab Invest; 1987 Jun; 47(4):405-10. PubMed ID: 2440098 [TBL] [Abstract][Full Text] [Related]
17. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Goldstein W; Döring G Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673 [TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar lavage fluid and plasma proteins, chemiluminescence response and protein contents of polymorphonuclear leukocytes from blood and lavage fluid in traumatized patients. Dwenger A; Schweitzer G; Regel G J Clin Chem Clin Biochem; 1986 Jan; 24(1):73-88. PubMed ID: 3701271 [TBL] [Abstract][Full Text] [Related]